SLU-PP-332 5mg

SLU-PP-332 is provided as a 5 mg lyophilized powder in a sterile, sealed research vial. Each batch undergoes independent third-party analysis (HPLC and/or Mass Spectrometry) to verify purity and identity.
This compound is intended strictly for laboratory research use only. It is not for human consumption, nor for use in veterinary or clinical applications.
SLU‑PP‑332 is a synthetic small-molecule peptide-like compound developed at Saint Louis University School of Medicine. It functions as a potent pan-agonist of estrogen-related receptors (ERRα, ERRβ, and ERRγ), with highest affinity for ERRα (EC₅₀ ≈ 98 nM). In preclinical research, this compound mimics key effects of endurance exercise—such as enhanced energy metabolism, mitochondrial biogenesis, and fat oxidation—while not influencing estrogen receptor pathways.